相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Bone marrow lesions in hip osteoarthritis are characterized by increased bone turnover and enhanced angiogenesis
M. Shabestari et al.
OSTEOARTHRITIS AND CARTILAGE (2016)
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
Robert L. Avery et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Bevacizumab-Associated Osteonecrosis of the Wrist and Knee in Three Pediatric Patients With Recurrent CNS Tumors
Jason Fangusaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Osteonecrosis of the mandible associated with bevacizumab therapy
Alan Roger Santos-Silva et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2013)
Osteonecrosis After Administration of Intravitreous Bevacizumab
Renato Nicolas Hopp et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2012)
Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: Effectiveness of an injection protocol based on the vascular anatomy of the nose
Sinan Dheyauldeen et al.
LARYNGOSCOPE (2012)
Bone marrow lesions: a universal bone response to injury?
Erik Fink Eriksen et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Osteonecrosis of the Knee and Related Conditions
Michael A. Mont et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2011)
Safety of Intranasal Bevacizumab (Avastin) Treatment in Patients with Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis
Sonia Chen et al.
LARYNGOSCOPE (2011)
Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials
Sabine Geiger-Gritsch et al.
ONCOLOGIST (2010)